Your browser doesn't support javascript.
loading
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Jiao, Xiang; Aravidis, Christos; Marikkannu, Rajeshwari; Rantala, Johanna; Picelli, Simone; Adamovic, Tatjana; Liu, Tao; Maguire, Paula; Kremeyer, Barbara; Luo, Liping; von Holst, Susanna; Kontham, Vinaykumar; Thutkawkorapin, Jessada; Margolin, Sara; Du, Quan; Lundin, Johanna; Michailidou, Kyriaki; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Lush, Michael; Ambrosone, Christine B; Andrulis, Irene L; Anton-Culver, Hoda; Antonenkova, Natalia N; Arndt, Volker; Beckmann, Matthias W; Blomqvist, Carl; Blot, William; Boeckx, Bram; Bojesen, Stig E; Bonanni, Bernardo; Brand, Judith S; Brauch, Hiltrud; Brenner, Hermann; Broeks, Annegien; Brüning, Thomas; Burwinkel, Barbara; Cai, Qiuyin; Chang-Claude, Jenny; Couch, Fergus J; Cox, Angela; Cross, Simon S; Deming-Halverson, Sandra L; Devilee, Peter; Dos-Santos-Silva, Isabel; Dörk, Thilo; Eriksson, Mikael; Fasching, Peter A; Figueroa, Jonine.
Afiliação
  • Jiao X; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Aravidis C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Marikkannu R; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Rantala J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Picelli S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Adamovic T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Liu T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Maguire P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kremeyer B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Luo L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • von Holst S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kontham V; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Thutkawkorapin J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Margolin S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Du Q; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lundin J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Michailidou K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wang Q; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ambrosone CB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Anton-Culver H; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Antonenkova NN; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Arndt V; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Beckmann MW; Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
  • Blomqvist C; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Blot W; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Boeckx B; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Bojesen SE; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Bonanni B; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Brand JS; International Epidemiology Institute, Rockville, MD, USA.
  • Brauch H; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Brenner H; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Broeks A; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brüning T; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Burwinkel B; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Cai Q; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Chang-Claude J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Couch FJ; University of Tübingen, Tübingen, Germany.
  • Cox A; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Deming-Halverson SL; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Devilee P; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Dos-Santos-Silva I; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Dörk T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
  • Eriksson M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Fasching PA; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Figueroa J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Oncotarget ; 8(61): 102769-102782, 2017 Nov 28.
Article em En | MEDLINE | ID: mdl-29262523
ABSTRACT
Most non-BRCA1/2 breast cancer families have no identified genetic cause. We used linkage and haplotype analyses in familial and sporadic breast cancer cases to identify a susceptibility locus on chromosome 6q. Two independent genome-wide linkage analysis studies suggested a 3 Mb locus on chromosome 6q and two unrelated Swedish families with a LOD >2 together seemed to share a haplotype in 6q14.1. We hypothesized that this region harbored a rare high-risk founder allele contributing to breast cancer in these two families. Sequencing of DNA and RNA from the two families did not detect any pathogenic mutations. Finally, 29 SNPs in the region were analyzed in 44,214 cases and 43,532 controls from BCAC, and the original haplotypes in the two families were suggested as low-risk alleles for European and Swedish women specifically. There was also some support for one additional independent moderate-risk allele in Swedish familial samples. The results were consistent with our previous findings in familial breast cancer and supported a breast cancer susceptibility locus at 6q14.1 around the PHIP gene.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article